Jin Medical International Balance Sheet Health
Financial Health criteria checks 4/6
Jin Medical International has a total shareholder equity of $26.2M and total debt of $9.7M, which brings its debt-to-equity ratio to 37%. Its total assets and total liabilities are $41.2M and $15.0M respectively. Jin Medical International's EBIT is $2.3M making its interest coverage ratio -3. It has cash and short-term investments of $26.0M.
Key information
37.0%
Debt to equity ratio
US$9.68m
Debt
| Interest coverage ratio | -3x |
| Cash | US$25.99m |
| Equity | US$26.15m |
| Total liabilities | US$15.01m |
| Total assets | US$41.16m |
Recent financial health updates
Recent updates
Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Oct 30
Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%
Sep 07Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly
Aug 24Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%
Jul 24Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal
Jul 17Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Jun 04Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up
Dec 27What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You
Sep 29Financial Position Analysis
Short Term Liabilities: ZJYL's short term assets ($38.2M) exceed its short term liabilities ($14.8M).
Long Term Liabilities: ZJYL's short term assets ($38.2M) exceed its long term liabilities ($179.7K).
Debt to Equity History and Analysis
Debt Level: ZJYL has more cash than its total debt.
Reducing Debt: ZJYL's debt to equity ratio has increased from 18.2% to 37% over the past 5 years.
Debt Coverage: ZJYL's debt is not well covered by operating cash flow (4.3%).
Interest Coverage: ZJYL earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 01:07 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jin Medical International Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|